Molecular hydrogen suppresses glioblastoma growth via inducing the glioma stem-like cell differentiation

被引:0
作者
Meng-yu Liu
Fei Xie
Yan Zhang
Ting-ting Wang
Sheng-nan Ma
Peng-xiang Zhao
Xin Zhang
Tyler W. Lebaron
Xin-long Yan
Xue-mei Ma
机构
[1] Beijing University of Technology,College of Life Science and Bio
[2] Beijing Molecular Hydrogen Research Center,engineering
[3] Affiliated Bayi Brain Hospital,Center of Experimental Medicine, Institute for Heart Research
[4] The Seventh Medical Center of PLA General Hospital,undefined
[5] Correction is Molecular Hydrogen Institute,undefined
[6] Slovak Academy of Sciences,undefined
来源
Stem Cell Research & Therapy | / 10卷
关键词
Molecular hydrogen; Glioblastoma; Glioma stem-like cell; Cancer cell stemness;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 115 条
[1]  
Bastiancich C(2018)Gemcitabine and glioblastoma: challenges and current perspectives Drug Discov Today 23 416-423
[2]  
Bastiat G(2018)New directions in the treatment of glioblastoma Semin Neurol 38 50-61
[3]  
Lagarce F(2018)Repurposing drugs for glioblastoma: from bench to bedside Cancer Lett 428 173-183
[4]  
Reitman ZJ(2018)Epidemiology of brain tumors Neurol Clin 36 395-419
[5]  
Winkler F(2007)Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals Nat Med 13 688-694
[6]  
Elia A(2015)Beneficial biological effects and the underlying mechanisms of molecular hydrogen – comprehensive review of 321 original articles Med Gas Res. 5 12-154
[7]  
Basso J(1975)Hyperbaric hydrogen therapy: a possible treatment for cancer Science. 190 152-255
[8]  
Miranda A(2008)Neutral pH hydrogen-enriched electrolyzed water achieves tumor-preferential clonal growth inhibition over normal cells and tumor invasion inhibition concurrently with intracellular oxidant repression Oncol Res 17 247-797
[9]  
Sousa J(2018)Hydrogen gas inhibits lung cancer progression through targeting SMC3 Biomed Pharmacother 104 788-2190
[10]  
Pais A(2018)Therapeutic efficacy of hydrogen-rich saline alone and in combination with PI3K inhibitor in non-small cell lung cancer Mol Med Rep 18 2182-995